mRNA |
BRD-A02303741:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.2 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
BIRB 0796 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
erismodegib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
PF-3758309 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.2 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |